Education

University of California, Berkeley, B.A., 01/2006, Molecular and Cell Biology
New York University School of Medicine, M.D., 01/2015, Medicine
New York University Sackler Institute, Ph.D., 01/2013, Developmental Genetics
University of California, San Francisco, Resident, 01/2018, Anatomic Pathology
University of California, San Francisco, Fellow, 01/2018, Surgical Pathology

Honors & Awards

  • 2002
    Regents' Scholarship, University of California, Berkeley
  • 2005
    Biology Fellows Program Semester Research Grant (Mentor: John Coates), University of California, Berkeley
  • 2007
    Summer Scholarship for Medical Students (Mentor: Joel Ernst), Infectious Diseases Society of America
  • 2008
    Award for Academic Excellence and Achievement, American Society of Clinical Pathology
  • 2011
    3rd place poster prize, 18th International C. elegans Meeting, Genetics Society of America
  • 2016
    Chief Resident, Department of Pathology, San Francisco VA Medical Center
  • 2016
    Pathologist in Training Travel Award, 92nd Annual AANP Meeting, American Association of Neuropathologists
  • 2017
    Chief Resident, Department of Pathology, San Francisco General Hospital
  • 2017
    Pathologist in Training Travel Award, USCAP Annual Meeting, United States and Canadian Academy of Pathology
  • 2017
    Visiting scholar. Genitourinary pathology. Mentor: Victor Reuter. 1 month., Memorial Sloan Kettering Cancer Center
  • 2018
    Visiting scholar. Genitourinary pathology. Mentor Jesse McKenney. 1 month., Cleveland Clinic

Selected Publications

  1. de Kouchkovsky I, Zhang L, Philip EJ, Wright F, Kim DM, Natesan D, Kwon D, Ho H, Ho S, Chan E, Porten SP, Wong AC, Desai A, Huang FW, Chou J, Oh DY, Pruthi RS, Fong L, Small EJ, Friedlander TW, Koshkin VS. TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor. J Immunother Cancer. 2021 05; 9(5).  View on PubMed
  2. Greenland NY, Cowan JE, Chan E, Carroll PR, Stohr BA, Simko JP. Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category. Prostate. 2020 12; 80(16):1421-1428.  View on PubMed
  3. Anderson JA, Matoso A, Murati Amador BI, Cheng L, Stohr BA, Chan E, Osunkoya AO. Invasive poorly differentiated adenocarcinoma of the bladder following augmentation cystoplasty: a multi-institutional clinicopathological study. Pathology. 2021 Feb; 53(2):214-219.  View on PubMed
  4. van Leenders GJLH, van der Kwast TH, Grignon DJ, Evans AJ, Kristiansen G, Kweldam CF, Litjens G, McKenney JK, Melamed J, Mottet N, Paner GP, Samaratunga H, Schoots IG, Simko JP, Tsuzuki T, Varma M, Warren AY, Wheeler TM, Williamson SR, Iczkowski KA, ISUP Grading Workshop Panel Members . The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. Am J Surg Pathol. 2020 08; 44(8):e87-e99.  View on PubMed
  5. Sangoi AR, Chan E, Stohr BA, Kunju LP. Invasive plasmacytoid urothelial carcinoma: A comparative study of E-cadherin and P120 catenin. Hum Pathol. 2020 08; 102:54-59.  View on PubMed
  6. Chan E, Stohr BA, Croom NA, Cho SJ, Garg K, Troxell ML, Higgins JP, Bean GR. Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution. Histopathology. 2020 Jun; 76(7):1084-1090.  View on PubMed
  7. Chan E, Garg K, Stohr BA. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer. Mod Pathol. 2020 09; 33(9):1802-1810.  View on PubMed
  8. Greenland NY, Cowan JE, Zhang L, Carroll PR, Chan E, Stohr BA, Simko JP. Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4. Prostate. 2020 05; 80(8):653-659.  View on PubMed
  9. Cox RM, Chan E, Sangoi AR, Zou Y, McKenney JK. STAT6 monoclonal antibody is highly specific for the distinction between solitary fibrous tumour and prostatic stromal proliferations. Histopathology. 2020 03; 76(4):625-626.  View on PubMed
  10. Lau HD, Chan E, Fan AC, Kunder CA, Williamson SR, Zhou M, Idrees MT, Maclean FM, Gill AJ, Kao CS. A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients. Am J Surg Pathol. 2020 01; 44(1):98-110.  View on PubMed
  11. Chan E, Rabban JT, Mak J, Zaloudek C, Garg K. Detailed Morphologic and Immunohistochemical Characterization of Myomectomy and Hysterectomy Specimens From Women With Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC). Am J Surg Pathol. 2019 09; 43(9):1170-1179.  View on PubMed
  12. Larson AR, Kemmer J, Formeister E, El-Sayed I, Ha P, George J, Ryan W, Chan E, Heaton C. Beyond Depth of Invasion: Adverse Pathologic Tumor Features in Early Oral Tongue Squamous Cell Carcinoma. Laryngoscope. 2020 07; 130(7):1715-1720.  View on PubMed
  13. Rabban JT, Chan E, Mak J, Zaloudek C, Garg K. Prospective Detection of Germline Mutation of Fumarate Hydratase in Women With Uterine Smooth Muscle Tumors Using Pathology-based Screening to Trigger Genetic Counseling for Hereditary Leiomyomatosis Renal Cell Carcinoma Syndrome: A 5-Year Single Institutional Experience. Am J Surg Pathol. 2019 05; 43(5):639-655.  View on PubMed
  14. Chan E, Balassanian R, Tabatabai ZL, Lou H, Vohra P. Improved diagnostic precision of urine cytology by implementation of The Paris System and the use of cell blocks. Cancer Cytopathol. 2018 09; 126(9):809-816.  View on PubMed
  15. Chan E, Bollen AW, Sirohi D, Van Ziffle J, Grenert JP, Kline CN, Tihan T, Perry A, Gupta N, Solomon DA. Angiocentric glioma with MYB-QKI fusion located in the brainstem, rather than cerebral cortex. Acta Neuropathol. 2017 Oct; 134(4):671-673.  View on PubMed
  16. Armenti ST, Chan E, Nance J. Polarized exocyst-mediated vesicle fusion directs intracellular lumenogenesis within the C. elegans excretory cell. Dev Biol. 2014 Oct 01; 394(1):110-21.  View on PubMed
  17. Chan E, Nance J. Mechanisms of CDC-42 activation during contact-induced cell polarization. J Cell Sci. 2013 Apr 01; 126(Pt 7):1692-702.  View on PubMed
  18. O'Neil BH, Raftery L, Calvo BF, Chakravarthy AB, Ivanova A, Myers MO, Kim HJ, Chan E, Wise PE, Caskey LS, Bernard SA, Sanoff HK, Goldberg RM, Tepper JE. A phase I study of bortezomib in combination with standard 5-fluorouracil and external-beam radiation therapy for the treatment of locally advanced or metastatic rectal cancer. Clin Colorectal Cancer. 2010 Apr; 9(2):119-25.  View on PubMed
  19. Chakraborty R, O'Connor SM, Chan E, Coates JD. Anaerobic degradation of benzene, toluene, ethylbenzene, and xylene compounds by Dechloromonas strain RCB. Appl Environ Microbiol. 2005 Dec; 71(12):8649-55.  View on PubMed
  20. Wang W, Chan EK, Baron S, Van de Water T, Lufkin T. Hmx2 homeobox gene control of murine vestibular morphogenesis. Development. 2001 Dec; 128(24):5017-29.  View on PubMed

Go to UCSF Profiles, powered by CTSI